GM-CSF Knock-out in CAR-T Cells by CRISPR/Cas9 | Protocol Preview

CRISPR/Cas9 Gene Knockouts Generation in Mammalian Cells | Protocol PreviewПодробнее

CRISPR-Engineered CAR-T Cells Production | Protocol PreviewПодробнее

CRISPR/Cas9-based genome editing for autologous CAR-T cell productionПодробнее

Genome Engineering Of Primary Human B Cells Using CRISPR/Cas9 l Protocol PreviewПодробнее

Construction-CRISPR Plasmids & Detection-Knockout Efficiency In Mammalian Cells l Protocol PreviewПодробнее

CAR T Cells Production for Adoptive Immunotherapy | Protocol PreviewПодробнее

Using CRISPR/Cas9 gene editing to generate NKG2A-knockout CD33-CAR-NK cells for the treatment of AMLПодробнее

CRISPR/Cas9 used for Gene-Knock in and Cell Sorting | Protocol PreviewПодробнее

Impact of GM-CSF neutralization vs receptor blockade in pre-clinical models of CAR-T therapyПодробнее

Targeting T-cell malignancies with CRISPR/Cas9 gene edited universal CAR-TПодробнее

How to Screen for CRISPR Knock Out CellsПодробнее

Validation of eIF4A1 by CRISPR-Cas9 knockoutПодробнее

High-throughput CRISPR-Cas9 Genome Engineering in Primary T CellsПодробнее

Using CRISPR and non-viral DNA in T Cell EngineeringПодробнее

Professor Waseem Qasim - TALEN, CRISPR and base edited CAR T-cells for ALLПодробнее

Use of CRISPR/Cas9 in CAR-T cell TherapyПодробнее

CRISPR/Cas9 Genetic Screens for Cell Surface Receptor Identification | Protocol PreviewПодробнее

How are CAR-T Therapies Manufactured?Подробнее

How to perform a CRISPR Knockin ExperimentПодробнее